Overview

A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy

Status:
NOT_YET_RECRUITING
Trial end date:
2026-10-30
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the effect on body weight in subjects taking semaglutide injection or subjects taking Wegovy.
Phase:
PHASE3
Details
Lead Sponsor:
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Treatments:
semaglutide